| scholarly article | Q13442814 |
| P50 | author | Friedemann Weber | Q40182480 |
| Matthias Habjan | Q46151229 | ||
| P2093 | author name string | Martin Spiegel | |
| Nicola Penski | |||
| P2860 | cites work | Robust hepatitis C virus infection in vitro | Q27470013 |
| Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication | Q27472912 | ||
| P433 | issue | Pt 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Rift Valley fever | Q326638 |
| Rift Valley fever virus | Q14276794 | ||
| Rift Valley fever phlebovirus | Q24809101 | ||
| P304 | page(s) | 2157-2166 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | Journal of General Virology | Q6295245 |
| P1476 | title | T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus | |
| P478 | volume | 89 |
| Q40186455 | A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep. |
| Q35587097 | A virus-like particle system identifies the endonuclease domain of Crimean-Congo hemorrhagic fever virus |
| Q34170442 | Analysis of the Tomato spotted wilt virus ambisense S RNA-encoded hairpin structure in translation |
| Q24599295 | Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies |
| Q38808444 | Association of Rift Valley fever virus infection with miscarriage in Sudanese women: a cross-sectional study |
| Q33796167 | Capped antigenomic RNA transcript facilitates rescue of a plant rhabdovirus |
| Q59349693 | Cell cycle arrest in G2/M phase enhances replication of interferon-sensitive cytoplasmic RNA viruses via inhibition of antiviral gene expression |
| Q28486276 | Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus |
| Q38934641 | Construction of an infectious molecular clone of Japanese encephalitis virus genotype V and its derivative subgenomic replicon capable of expressing a foreign gene |
| Q33705717 | Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs |
| Q35531617 | Creation of a nonspreading Rift Valley fever virus |
| Q38748778 | Creation of a recombinant Rift Valley fever virus with a two-segmented genome |
| Q33558533 | Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function |
| Q41929716 | Current Status of Rift Valley Fever Vaccine Development |
| Q30855840 | Dengue virus activates cGAS through the release of mitochondrial DNA |
| Q88486719 | Discovery and development of safe-in-man broad-spectrum antiviral agents |
| Q35107614 | Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. |
| Q39893246 | Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses |
| Q92667969 | Elongin C Contributes to RNA Polymerase II Degradation by the Interferon Antagonist NSs of La Crosse Orthobunyavirus |
| Q39223078 | Establishment of a reverse genetics system for Schmallenberg virus, a newly emerged orthobunyavirus in Europe |
| Q57009189 | Extensive recoding of dengue virus type 2 specifically reduces replication in primate cells without gain-of-function in Aedes aegypti mosquitoes |
| Q37744980 | Foot-and-mouth disease virus infection suppresses autophagy and NF-кB antiviral responses via degradation of ATG5-ATG12 by 3Cpro. |
| Q91801627 | Generation of a GFP Reporter Akabane Virus with Enhanced Fluorescence Intensity by Modification of Artificial Ambisense S Genome |
| Q38855194 | Generation of a Recombinant Akabane Virus Expressing Enhanced Green Fluorescent Protein |
| Q44170263 | Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells |
| Q35893112 | High-Throughput Screening Using a Whole-Cell Virus Replication Reporter Gene Assay to Identify Inhibitory Compounds against Rift Valley Fever Virus Infection |
| Q39187107 | Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus |
| Q99546647 | ISG15 overexpression compensates the defect of Crimean-Congo hemorrhagic fever virus polymerase bearing a protease-inactive ovarian tumor domain |
| Q39241501 | Identification of amino acid residues important for anti-IFN activity of porcine reproductive and respiratory syndrome virus non-structural protein 1. |
| Q33915111 | Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling |
| Q34993512 | Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation |
| Q45372924 | Interventions Against West Nile Virus, Rift Valley Fever Virus, and Crimean-Congo Hemorrhagic Fever Virus: Where Are We? |
| Q35484845 | Large-scale recoding of an arbovirus genome to rebalance its insect versus mammalian preference |
| Q36650409 | Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses |
| Q57017486 | Molecular Biology of Rift Valley Fever Virus~!2009-11-04~!2009-11-25~!2010-04-22~! |
| Q33886954 | Molecular biology of rift valley Fever virus |
| Q42614498 | Mutational analysis of the Bunyamwera orthobunyavirus nucleocapsid protein gene |
| Q59352330 | NSs Protein of Sandfly Fever Sicilian Phlebovirus Counteracts Interferon (IFN) Induction by Masking the DNA-Binding Domain of IFN Regulatory Factor 3 |
| Q39195523 | NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase |
| Q39778891 | Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. |
| Q26747457 | Phleboviruses and the Type I Interferon Response |
| Q48097495 | Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection |
| Q36669639 | Poxviruses Encode a Reticulon-Like Protein that Promotes Membrane Curvature |
| Q36668959 | Protein Phosphatase-1 regulates Rift Valley fever virus replication |
| Q33422481 | Recovery of Recombinant Crimean Congo Hemorrhagic Fever Virus Reveals a Function for Non-structural Glycoproteins Cleavage by Furin |
| Q30413201 | Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines |
| Q35718193 | Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection |
| Q38970464 | Rescue of recombinant Newcastle disease virus: current cloning strategies and RNA polymerase provision systems. |
| Q38780584 | Reverse genetics in high throughput: rapid generation of complete negative strand RNA virus cDNA clones and recombinant viruses thereof. |
| Q33570326 | Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines |
| Q39251803 | Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate. |
| Q40308414 | Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection. |
| Q33960690 | Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention |
| Q26795706 | Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe |
| Q33405724 | Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines |
| Q36326847 | Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates |
| Q39734555 | Species-independent bioassay for sensitive quantification of antiviral type I interferons |
| Q92133633 | Stable Occupancy of the Crimean-Congo Hemorrhagic Fever Virus-Encoded Deubiquitinase Blocks Viral Infection |
| Q34734608 | Systems to establish bunyavirus genome replication in the absence of transcription |
| Q64091447 | The 3' Untranslated Region of a Plant Viral RNA Directs Efficient Cap-Independent Translation in Plant and Mammalian Systems |
| Q92800161 | The Curious Case of the Nidovirus Exoribonuclease: Its Role in RNA Synthesis and Replication Fidelity |
| Q64252092 | The One Health Approach is Necessary for the Control of Rift Valley Fever Infections in Egypt: A Comprehensive Review |
| Q99557062 | The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2 |
| Q34634852 | The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses |
| Q34097995 | Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice. |
| Q35841573 | Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy |
| Q55546604 | VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9. |
| Q40399200 | Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus |
| Q29147519 | Viperin is an iron-sulfur protein that inhibits genome synthesis of tick-borne encephalitis virus via radical SAM domain activity |
| Q24293704 | Viral immune modulators perturb the human molecular network by common and unique strategies |
| Q38326807 | Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH |
| Q97519293 | eIF2B as a Target for Viral Evasion of PKR-Mediated Translation Inhibition |
| Q35825427 | iTRAQ protein profile analysis of neuroblastoma (NA) cells infected with the rabies viruses rHep-Flury and Hep-dG. |
Search more.